Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 23, Pages e2103730118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-06-05
DOI
10.1073/pnas.2103730118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
- (2020) Alok Kumar et al. eLife
- Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade
- (2019) Amy L. Shergold et al. PHARMACOLOGICAL RESEARCH
- Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer
- (2019) Jaclyn Sceneay et al. Cancer Discovery
- Functional genomics: paving the way for more successful cancer immunotherapy
- (2018) Reham Ajina et al. Briefings in Functional Genomics
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Xenogeneic cell therapy provides a novel potential therapeutic option for cancers by restoring tissue function, repairing cancer wound and reviving anti-tumor immune responses
- (2018) Chi-Ping Huang et al. Cancer Cell International
- Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model
- (2018) Álvaro Padrón et al. EXPERIMENTAL GERONTOLOGY
- Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs
- (2018) Denise R. Minton et al. MOLECULAR CELL
- Inhibition of CD45 Phosphatase Activity Induces Cell Cycle Arrest and Apoptosis of CD45+Lymphoid Tumors Ex Vivo and In Vivo
- (2018) Michael Perron et al. MOLECULAR PHARMACOLOGY
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Mitochondrial translation requires folate-dependent tRNA methylation
- (2018) Raphael J. Morscher et al. NATURE
- PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy
- (2018) Partha S. Chowdhury et al. Cancer Immunology Research
- The Changing Landscape of Naive T Cell Receptor Repertoire With Human Aging
- (2018) Evgeny S. Egorov et al. Frontiers in Immunology
- Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice
- (2018) Noga Ron-Harel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy
- (2017) P. S. Chowdhury et al. JOURNAL OF INTERNAL MEDICINE
- Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
- (2017) Kenji Chamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation
- (2016) Noga Ron-Harel et al. Cell Metabolism
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
- (2016) Nicole E. Scharping et al. IMMUNITY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-Affinity Memory CD8+T Cells Mediate Robust Heterologous Immunity
- (2016) Scott M. Krummey et al. JOURNAL OF IMMUNOLOGY
- Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure
- (2016) Clovis S. Palmer et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- The development of immunotherapy in older adults: New treatments, new toxicities?
- (2016) Carole Helissey et al. Journal of Geriatric Oncology
- CD45-mediated control of TCR tuning in naïve and memory CD8+ T cells
- (2016) Jae-Ho Cho et al. Nature Communications
- Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation
- (2016) Nicolas Degauque et al. Frontiers in Immunology
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age
- (2015) Hirotake Tsukamoto et al. Nature Communications
- Effector CD8 T Cell Development: A Balancing Act between Memory Cell Potential and Terminal Differentiation
- (2014) N. S. Joshi et al. JOURNAL OF IMMUNOLOGY
- Clonal Expansions and Loss of Receptor Diversity in the Naive CD8 T Cell Repertoire of Aged Mice
- (2014) M. Ahmed et al. JOURNAL OF IMMUNOLOGY
- Aging of the T Cell Compartment in Mice and Humans: From No Naive Expectations to Foggy Memories
- (2014) Janko Nikolich-Žugich JOURNAL OF IMMUNOLOGY
- Diversity and clonal selection in the human T-cell repertoire
- (2014) Q. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- T-cell memory differentiation: insights from transcriptional signatures and epigenetics
- (2013) Ben Youngblood et al. IMMUNOLOGY
- Allogeneic tumor cell vaccines
- (2013) Sanjay Srivatsan et al. Human Vaccines & Immunotherapeutics
- Molecular Insights for Optimizing T Cell Receptor Specificity Against Cancer
- (2013) Michael Hebeisen et al. Frontiers in Immunology
- Lymphopenia-Driven Homeostatic Regulation of Naive T Cells in Elderly and Thymectomized Young Adults
- (2012) D. Sauce et al. JOURNAL OF IMMUNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-related changes in CD8 T cell homeostasis and immunity to infection
- (2012) Janko Nikolich-Žugich et al. SEMINARS IN IMMUNOLOGY
- How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism
- (2012) Jérémie Rossy et al. Frontiers in Immunology
- Assessing mitochondrial dysfunction in cells
- (2011) Martin D. Brand et al. BIOCHEMICAL JOURNAL
- TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition
- (2011) L. J. D’Orsogna et al. IMMUNOGENETICS
- Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions
- (2011) Jeffrey C Nolz et al. Immunotherapy
- ZAP-70: An Essential Kinase in T-cell Signaling
- (2010) H. Wang et al. Cold Spring Harbor Perspectives in Biology
- T-cell immunosenescence: lessons learned from mouse models of aging
- (2009) Alexander C. Maue et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started